Why the study?
Does the rate of disappearance of 131I-labelled fibrinogen identify a hypercoagulable state in human subjects?
Population
43 human subjects, including patients with thromboembolic disease and patients following extensive surgical…
Design
Cohort
Authors
Loading...
Shortened fibrinogen half-life may flag hypercoagulability before thrombosis; hypothesis-generating for its use as an early biomarker pending validation.
Does the rate of disappearance of 131I-labelled fibrinogen identify a hypercoagulable state in human subjects?
The shortened half-life of 131I-labelled fibrinogen may serve as a diagnostic marker for a hypercoagulable state preceding clinical thromboembolic events.
Izak et al. (1967) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: